Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Samantha M. Sarett"'
Autor:
Craig L. Duvall, Rebecca S. Cook, Dana M. Brantley-Sieders, Samantha M. Sarett, Somtochukwu C. Dimobi, Kameron V. Kilchrist, Paula Gonzalez Ericsson, Violeta Sanchez, Donna J. Hicks, Linus H. Lee, Meghan Morrison Joly, Taylor E. Kavanaugh, Meredith A. Jackson, Shan Wang, Thomas A. Werfel
Supplemental Figures S1-9 Supplemental Figure S1 - Table of Oligos Supplemental Figures S2-5 - Scheme of chemical synthesis and characterization of polymers Supplemental Figure S6 - Basic in vitro characterization of si-NPs Supplemental Figure S7 - T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f85d61b430296663b3ff687420dc690
https://doi.org/10.1158/0008-5472.22417482.v1
https://doi.org/10.1158/0008-5472.22417482.v1
Autor:
Craig L. Duvall, Rebecca S. Cook, Dana M. Brantley-Sieders, Samantha M. Sarett, Somtochukwu C. Dimobi, Kameron V. Kilchrist, Paula Gonzalez Ericsson, Violeta Sanchez, Donna J. Hicks, Linus H. Lee, Meghan Morrison Joly, Taylor E. Kavanaugh, Meredith A. Jackson, Shan Wang, Thomas A. Werfel
Small-molecule inhibitors of the mTORC2 kinase (torkinibs) have shown efficacy in early clinical trials. However, the torkinibs under study also inhibit the other mTOR-containing complex mTORC1. While mTORC1/mTORC2 combined inhibition may be benefici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcd5836b276f4568e4674c7ef5a94558
https://doi.org/10.1158/0008-5472.c.6509856
https://doi.org/10.1158/0008-5472.c.6509856
Autor:
Alexandra McMillan, Peilin Ge, Cong Truc Huynh, Craig L. Duvall, Melanie Chetverikova, Minh Khanh Nguyen, Kien Nguyen, Samantha M. Sarett, Eben Alsberg, David Grosh
Publikováno v:
Acta Biomater
Delivery systems for controlled release of RNA interference (RNAi) molecules, including small interfering (siRNA) and microRNA (miRNA), have the potential to direct stem cell differentiation for regenerative musculoskeletal applications. To date, loc
Autor:
Paula Gonzalez Ericsson, Meghan Morrison Joly, Rebecca S. Cook, Violeta Sanchez, Samantha M. Sarett, Linus Lee, Meredith A. Jackson, Kameron V. Kilchrist, Shan Wang, Taylor E. Kavanaugh, Donna J. Hicks, Thomas A. Werfel, Dana M. Brantley-Sieders, Craig L. Duvall, Somtochukwu C. Dimobi
Publikováno v:
Cancer Research. 78:1845-1858
Small-molecule inhibitors of the mTORC2 kinase (torkinibs) have shown efficacy in early clinical trials. However, the torkinibs under study also inhibit the other mTOR-containing complex mTORC1. While mTORC1/mTORC2 combined inhibition may be benefici
Autor:
Craig L. Duvall, Samantha M. Sarett, Lillian B. Nanney, Nancy L. Cardwell, Jeffrey M. Davidson, Alonda C. Pollins, John R. Martin, Scott A. Guelcher, Prarthana Patil
Publikováno v:
Tissue Engineering Part C: Methods. 23:754-762
Impaired wound healing that mimics chronic human skin pathologies is difficult to achieve in current animal models, hindering testing and development of new therapeutic biomaterials that promote wound healing. In this article, we describe a refinemen
Autor:
Craig L. Duvall, Madison E. Hattaway, Thomas A. Werfel, Samantha M. Sarett, Meredith A. Jackson, Irene Chandra, Taylor E. Kavanaugh, Todd D. Giorgio
Publikováno v:
Biomaterials. 97:122-132
Formation of stable, long-circulating siRNA polyplexes is a significant challenge in translation of intravenously-delivered, polymeric RNAi cancer therapies. Here, we report that siRNA hydrophobization through conjugation to palmitic acid (siPA) impr
Publikováno v:
Journal of Biomedical Materials Research Part A. 103:3107-3116
Clinical translation of siRNA therapeutics has been limited by the inability to effectively overcome the rigorous delivery barriers associated with intracellular-acting biologics. Here, to address both potency and longevity of siRNA gene silencing, p
Autor:
Craig L. Duvall, Thomas A. Werfel, Linus Lee, Samantha M. Sarett, Meredith A. Jackson, Kameron V. Kilchrist, Dana M. Brantley-Sieders
Clinical translation of therapies based on small interfering RNA (siRNA) is hampered by siRNA's comprehensively poor pharmacokinetic properties, which necessitate molecule modifications and complex delivery strategies. We sought an alternative approa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99ff074213566429ddf91cd0afd89c36
https://europepmc.org/articles/PMC5558996/
https://europepmc.org/articles/PMC5558996/
Autor:
Samantha M. Sarett, Kameron V. Kilchrist, Meredith A. Jackson, Taylor E. Kavanaugh, Todd D. Giorgio, Ayisha N. Jackson, Elizabeth J. Curvino, Craig L. Duvall, Fang Yu, Thomas A. Werfel, Mary D. Dockery
Although siRNA-based nanomedicines hold promise for cancer treatment, conventional siRNA–polymer complex (polyplex) nanocarrier systems have poor pharmacokinetics following intravenous delivery, hindering tumor accumulation. Here, we determined the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3989b7dcda3899b5aed7fca4ca92143
https://europepmc.org/articles/PMC5919184/
https://europepmc.org/articles/PMC5919184/
Autor:
Samantha M. Sarett, Craig L. Duvall, Kelsey R. Beavers, Christopher E. Nelson, Martina Miteva
Publikováno v:
Nanomedicine. 8:329-332